Barclays Boosts The Cigna Group (NYSE:CI) Price Target to $420.00

The Cigna Group (NYSE:CI) had its target price upped by equities researchers at Barclays from $405.00 to $420.00 in a note issued to investors on Tuesday, Benzinga reports. The firm currently has an “overweight” rating on the health services provider’s stock. Barclays‘s price target would suggest a potential upside of 34.48% from the stock’s previous close.

CI has been the topic of a number of other research reports. JPMorgan Chase & Co. increased their price target on The Cigna Group from $435.00 to $438.00 and gave the company an “overweight” rating in a research note on Wednesday, August 21st. Cantor Fitzgerald restated an “overweight” rating and set a $400.00 target price on shares of The Cigna Group in a report on Wednesday, October 23rd. Stephens reiterated an “overweight” rating and issued a $410.00 price target on shares of The Cigna Group in a research report on Friday. StockNews.com cut shares of The Cigna Group from a “strong-buy” rating to a “buy” rating in a report on Monday. Finally, Jefferies Financial Group upped their target price on shares of The Cigna Group from $402.00 to $422.00 and gave the company a “buy” rating in a research note on Tuesday, September 17th. One research analyst has rated the stock with a hold rating, fourteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus target price of $395.07.

The Cigna Group Stock Down 1.3 %

Shares of CI opened at $312.32 on Tuesday. The firm has a market capitalization of $86.87 billion, a price-to-earnings ratio of 29.46, a PEG ratio of 0.96 and a beta of 0.51. The Cigna Group has a 52 week low of $253.95 and a 52 week high of $370.83. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.72 and a current ratio of 0.72. The business’s fifty day moving average price is $344.94 and its two-hundred day moving average price is $341.23.

The Cigna Group (NYSE:CI) last announced its quarterly earnings data on Thursday, October 31st. The health services provider reported $7.51 earnings per share for the quarter, topping the consensus estimate of $7.22 by $0.29. The firm had revenue of $63.70 billion during the quarter, compared to analysts’ expectations of $59.58 billion. The Cigna Group had a return on equity of 18.42% and a net margin of 1.31%. The company’s quarterly revenue was up 29.8% compared to the same quarter last year. During the same period in the previous year, the business posted $6.77 EPS. On average, analysts predict that The Cigna Group will post 28.48 earnings per share for the current year.

Insider Buying and Selling

In other The Cigna Group news, Director William J. Delaney III sold 2,691 shares of the business’s stock in a transaction dated Monday, August 19th. The shares were sold at an average price of $342.68, for a total transaction of $922,151.88. Following the sale, the director now directly owns 17,539 shares of the company’s stock, valued at $6,010,264.52. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. 0.70% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in CI. Cedar Wealth Management LLC bought a new stake in shares of The Cigna Group in the 1st quarter valued at about $29,000. TruNorth Capital Management LLC acquired a new position in The Cigna Group during the second quarter worth approximately $33,000. Ulland Investment Advisors LLC raised its stake in The Cigna Group by 2,500.0% in the third quarter. Ulland Investment Advisors LLC now owns 104 shares of the health services provider’s stock valued at $36,000 after buying an additional 100 shares during the period. Harbor Capital Advisors Inc. acquired a new stake in shares of The Cigna Group in the third quarter valued at approximately $45,000. Finally, Thurston Springer Miller Herd & Titak Inc. bought a new position in shares of The Cigna Group during the 2nd quarter worth approximately $66,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.